New Horizon Health Limited provided earnings guidance for the six months ended June 30, 2022. For the period, the company's total revenue is expected to be within the range of RMB 217.1 million to RMB 231.6 million, representing an increase in the range of 394.5% to 427.6% from approximately RMB 43.9 million for the six months ended June 30, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.14 HKD | -19.75% | -.--% | -38.92% |
08/04 | New Horizon Health Limited Announces Board Appointments | CI |
28/03 | New Horizon Health Limited Announces Delay in Publication Annual Results for the Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.92% | 812M | |
-4.62% | 12.18B | |
+8.48% | 5.96B | |
+28.39% | 5.45B | |
-6.28% | 4.34B | |
-52.84% | 3.18B | |
+12.93% | 2.75B | |
+28.84% | 2.3B | |
-3.80% | 2.28B | |
-4.64% | 1.92B |
- Stock Market
- Equities
- 6606 Stock
- News New Horizon Health Limited
- New Horizon Health Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022